secwatch.observer — SEC 8-K summary
======================================

Issuer:     enGene Therapeutics Inc. (ENGN)
CIK:        0001980845
Form:       8-K
Filed at:   2025-06-09T23:59:59+00:00
Accession:  0000950170-25-083444
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

enGene signs 5-year lease for 26,335 sq ft Boston office; parent guarantees rent
--------------------------------------------------------------------------------

- Lease with 99 High Street Owner LLC for office at 99 High Street, Boston, MA (26,335 rentable square feet).
- Initial term of 5 years 5 months, starting ~June 19, 2025; rent abated for first 5 months.
- Monthly base rent starts at ~$168,982 (Year 1) and escalates to ~$182,912 (Year 5), plus operating expenses and taxes.
- Parent enGene Holdings Inc. executed an unconditional guaranty of all Tenant obligations under the Lease.
- Rentable area is 3.60% of Building; base year for operating expenses is 2026, taxes fiscal year 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1980845/000095017025083444/0000950170-25-083444-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1980845/000095017025083444/engn-20250604.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-083444

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer